Quick Answer
Edesa Biotech, Inc. reported Total Revenue of $0.00 for fiscal year 2021.
Edesa Biotech, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2021 | $0.00 | -100.0% |
| 2020 | $328.8K | +55.2% |
| 2018 | $211.8K | -7.2% |
| 2017 | $228.3K | -82.0% |
| 2016 | $1.27M | +67.6% |
| 2015 | $758.7K | +1337.3% |
| 2014 | $52.8K | -85.8% |
| 2014 | $372.1K | -31.8% |
| 2013 | $545.5K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| June 30, 2021 | $0.00 | -100.0% | — |
| March 31, 2021 | $0.00 | -100.0% | — |
| December 31, 2020 | $0.00 | -100.0% | -100.0% |
| June 30, 2020 | $110.0K | +21897.0% | -0.5% |
| March 31, 2020 | $110.5K | — | +2.5% |
| December 31, 2019 | $107.8K | — | +21460.0% |
| June 30, 2019 | $500.00 | — | — |
| March 31, 2019 | $0.00 | -100.0% | — |
- Edesa Biotech, Inc. showed a decrease of -100.0% in Total Revenue compared to the prior fiscal year.
- Over the 2013–2021 period, Edesa Biotech, Inc.’s total revenue has declined by 100.0% (from $545.5 thousand to $0.00).
- The most recent figure is from Edesa Biotech, Inc.’s fiscal year 2021 report (Form 10-K), filed with the SEC on December 28, 2021.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: